Medication adherence star ratings measures, health care resource utilization, and cost.

IF 2.5 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Insiya B Poonawalla, Linda Chung, Sarah Shetler, Heather Pearce, Suzanne W Dixon, Patrick Racsa
{"title":"Medication adherence star ratings measures, health care resource utilization, and cost.","authors":"Insiya B Poonawalla, Linda Chung, Sarah Shetler, Heather Pearce, Suzanne W Dixon, Patrick Racsa","doi":"10.37765/ajmc.2024.89538","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To examine the association between missed CMS Star Ratings quality measures for medication adherence over 3 years for diabetes, hypertension, and hyperlipidemia medications (9 measures) and health care utilization and relative costs.</p><p><strong>Study design: </strong>Retrospective cohort study.</p><p><strong>Methods: </strong>The study examined eligible patients who qualified for the diabetes, statin, and renin-angiotensin system antagonist medication adherence measures in 2018, 2019, and 2020 and were continuously enrolled in a Medicare Advantage prescription drug plan from 2017 through 2021. A total of 103,900 patients were divided into 4 groups based on the number of adherence measures missed (3 medication classes over 3 years): (1) missed 0 measures, (2) missed 1 measure, (3) missed 2 or 3 measures, and (4) missed 4 or more measures. To achieve a quality measure, patients had to meet the Pharmacy Quality Alliance 80% threshold of proportion of days covered during the calendar year.</p><p><strong>Results: </strong>The mean age of the cohort was 71.1 years, and 49.9% were female. Compared with patients who missed 0 of 9 adherence measures, those who missed 1 measure, 2 or 3 measures, and 4 or more measures experienced 12% to 26%, 22% to 42%, and 24% to 50% increased risks, respectively, of all-cause and diabetes-related inpatient stays and all-cause and diabetes-related emergency department visits (all  P  values < .01). Additionally, patients who missed 1, 2 or 3, and 4 or more adherence measures experienced 14%, 19%, and 20% higher monthly medical costs, respectively.</p><p><strong>Conclusions: </strong>Missing Star Ratings quality measures for medication adherence was associated with an increased likelihood of health care resource utilization and increased costs for patients taking medications to treat diabetes, hypertension, and hyperlipidemia.</p>","PeriodicalId":50808,"journal":{"name":"American Journal of Managed Care","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Managed Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.37765/ajmc.2024.89538","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To examine the association between missed CMS Star Ratings quality measures for medication adherence over 3 years for diabetes, hypertension, and hyperlipidemia medications (9 measures) and health care utilization and relative costs.

Study design: Retrospective cohort study.

Methods: The study examined eligible patients who qualified for the diabetes, statin, and renin-angiotensin system antagonist medication adherence measures in 2018, 2019, and 2020 and were continuously enrolled in a Medicare Advantage prescription drug plan from 2017 through 2021. A total of 103,900 patients were divided into 4 groups based on the number of adherence measures missed (3 medication classes over 3 years): (1) missed 0 measures, (2) missed 1 measure, (3) missed 2 or 3 measures, and (4) missed 4 or more measures. To achieve a quality measure, patients had to meet the Pharmacy Quality Alliance 80% threshold of proportion of days covered during the calendar year.

Results: The mean age of the cohort was 71.1 years, and 49.9% were female. Compared with patients who missed 0 of 9 adherence measures, those who missed 1 measure, 2 or 3 measures, and 4 or more measures experienced 12% to 26%, 22% to 42%, and 24% to 50% increased risks, respectively, of all-cause and diabetes-related inpatient stays and all-cause and diabetes-related emergency department visits (all  P  values < .01). Additionally, patients who missed 1, 2 or 3, and 4 or more adherence measures experienced 14%, 19%, and 20% higher monthly medical costs, respectively.

Conclusions: Missing Star Ratings quality measures for medication adherence was associated with an increased likelihood of health care resource utilization and increased costs for patients taking medications to treat diabetes, hypertension, and hyperlipidemia.

用药依从性星级评定措施、医疗资源利用率和成本。
研究目的:研究 CMS 星级评定中关于糖尿病、高血压和高脂血症药物治疗的质量标准(9 项标准)在 3 年内的缺失与医疗使用和相对成本之间的关系:研究设计:研究设计:回顾性队列研究:该研究考察了 2018 年、2019 年和 2020 年符合糖尿病、他汀类药物和肾素-血管紧张素系统拮抗剂用药依从性衡量标准的合格患者,他们在 2017 年至 2021 年期间连续加入了医疗保险优势处方药计划。根据错过的依从性测量次数(3 年中的 3 种药物类别),共将 103,900 名患者分为 4 组:(1)错过 0 项措施;(2)错过 1 项措施;(3)错过 2 或 3 项措施;(4)错过 4 项或更多措施。要达到质量标准,患者必须达到药房质量联盟规定的 80% 的日历年内覆盖天数比例阈值:组群的平均年龄为 71.1 岁,49.9% 为女性。与缺失 9 项坚持治疗措施中 0 项措施的患者相比,缺失 1 项措施、2 或 3 项措施以及 4 项或更多措施的患者的全因住院风险和糖尿病相关住院风险,以及全因急诊就诊风险和糖尿病相关急诊就诊风险分别增加了 12% 至 26%、22% 至 42% 和 24% 至 50%(所有 P 值均为结论):对于服用药物治疗糖尿病、高血压和高血脂症的患者来说,错过星级评级中有关药物依从性的质量指标与医疗资源利用率和费用增加的可能性有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Managed Care
American Journal of Managed Care 医学-卫生保健
CiteScore
3.60
自引率
0.00%
发文量
177
审稿时长
4-8 weeks
期刊介绍: The American Journal of Managed Care is an independent, peer-reviewed publication dedicated to disseminating clinical information to managed care physicians, clinical decision makers, and other healthcare professionals. Its aim is to stimulate scientific communication in the ever-evolving field of managed care. The American Journal of Managed Care addresses a broad range of issues relevant to clinical decision making in a cost-constrained environment and examines the impact of clinical, management, and policy interventions and programs on healthcare and economic outcomes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信